Literature DB >> 8659517

A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q.

G T Fouad1, S Servidei, S Durcan, E Bertini, L J Ptácek.   

Abstract

Dyskinesias are hyperkinetic and involuntary movements that may result from any of a number of different genetic, infectious, and drug-induced causes. Some of the hereditary dyskinetic syndromes are characterized by paroxysmal onset of the abnormal movements. The classification of the familial paroxysmal dyskinesias (FPD) recognizes several distinct, although overlapping, phenotypes. Different forms of the disorder include attacks that are (1) induced by sudden movement (kinesiogenic); (2) spontaneous (non-kinesiogenic); and (3) induced by prolonged periods of exertion. Linkage analysis was pursued in a family segregating an autosomal dominant allele for non-kinesiogenic FPD. The disease allele was mapped to a locus on chromosome 2q31-36 (LOD score 4.64, theta = 0). Identification of distinct genetic loci for the paroxysmal dyskinesias will lead to a new genetic classification and to better understanding of these disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8659517      PMCID: PMC1915110     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  The predicted translation product of a cardiac AE3 mRNA contains an N terminus distinct from that of the brain AE3 Cl-/HCO3- exchanger. Cloning of a cardiac AE3 cDNA, organization of the AE3 gene, and identification of an alternative transcription initiation site.

Authors:  S C Linn; K E Kudrycki; G E Shull
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

2.  Molecular cloning, expression, and chromosomal localization of two isoforms of the AE3 anion exchanger from human heart.

Authors:  D Yannoukakos; A Stuart-Tilley; H A Fernandez; P Fey; G Duyk; S L Alper
Journal:  Circ Res       Date:  1994-10       Impact factor: 17.367

3.  Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia.

Authors:  R Shiang; S G Ryan; Y Z Zhu; A F Hahn; P O'Connell; J J Wasmuth
Journal:  Nat Genet       Date:  1993-12       Impact factor: 38.330

4.  A Met-to-Val mutation in the skeletal muscle Na+ channel alpha-subunit in hyperkalaemic periodic paralysis.

Authors:  C V Rojas; J Z Wang; L S Schwartz; E P Hoffman; B R Powell; R H Brown
Journal:  Nature       Date:  1991-12-05       Impact factor: 49.962

5.  Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis.

Authors:  L J Ptacek; L Gouw; H Kwieciński; P McManis; J R Mendell; R J Barohn; A L George; R L Barchi; M Robertson; M F Leppert
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

6.  Paroxysmal kinesigenic choreoathetosis with abnormal electroencephalogram during attacks.

Authors:  K Hirata; S Katayama; T Saito; K Ichihashi; T Mukai; M Katayama; T Otaka
Journal:  Epilepsia       Date:  1991 Jul-Aug       Impact factor: 5.864

7.  A calcium channel mutation causing hypokalemic periodic paralysis.

Authors:  K Jurkat-Rott; F Lehmann-Horn; A Elbaz; R Heine; R G Gregg; K Hogan; P A Powers; P Lapie; J E Vale-Santos; J Weissenbach
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

8.  Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita.

Authors:  L J Ptácek; A L George; R L Barchi; R C Griggs; J E Riggs; M Robertson; M F Leppert
Journal:  Neuron       Date:  1992-05       Impact factor: 17.173

9.  Temperature-sensitive mutations in the III-IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita.

Authors:  A I McClatchey; P Van den Bergh; M A Pericak-Vance; W Raskind; C Verellen; D McKenna-Yasek; K Rao; J L Haines; T Bird; R H Brown
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

10.  Dihydropyridine receptor mutations cause hypokalemic periodic paralysis.

Authors:  L J Ptácek; R Tawil; R C Griggs; A G Engel; R B Layzer; H Kwieciński; P G McManis; L Santiago; M Moore; G Fouad
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

View more
  17 in total

1.  Diagnosis and treatment of paroxysmal dyskinesias revisited.

Authors:  Iris Unterberger; Eugen Trinka
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

Review 2.  Diagnosis and management of acute movement disorders.

Authors:  D Dressler; R Benecke
Journal:  J Neurol       Date:  2005-10-10       Impact factor: 4.849

3.  Long-term improvement of paroxysmal dystonic choreathetosis with acetazolamide.

Authors:  Veronique Michel; Florence Riant; Elisabeth Tournier-Lasserve; Dominique Guehl; Alain Lagueny; Bernard Bioulac; Pierre Burbaud
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

4.  Mapping of the human Ca2+ channel beta 4 subunit to 2q22-23 and its expression in developing mouse.

Authors:  R Betz; B Leibiger; F Farnebo; S Lagercrantz; F Piehl; I Leibiger; C Larsson
Journal:  Mamm Genome       Date:  1998-04       Impact factor: 2.957

Review 5.  The dystonias.

Authors:  P R Jarman; T T Warner
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

6.  Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia.

Authors:  Hsien-yang Lee; Junko Nakayama; Ying Xu; Xueliang Fan; Maha Karouani; Yiguo Shen; Emmanuel N Pothos; Ellen J Hess; Ying-Hui Fu; Robert H Edwards; Louis J Ptácek
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

Review 7.  The epileptic and nonepileptic spectrum of paroxysmal dyskinesias: Channelopathies, synaptopathies, and transportopathies.

Authors:  Roberto Erro; Kailash P Bhatia; Alberto J Espay; Pasquale Striano
Journal:  Mov Disord       Date:  2017-01-16       Impact factor: 10.338

8.  Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1.

Authors:  H a Tomita; S Nagamitsu; K Wakui; Y Fukushima; K Yamada; M Sadamatsu; A Masui; T Konishi; T Matsuishi; M Aihara; K Shimizu; K Hashimoto; M Mineta; M Matsushima; T Tsujita; M Saito; H Tanaka; S Tsuji; T Takagi; Y Nakamura; S Nanko; N Kato; Y Nakane; N Niikawa
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

9.  Hereditary geniospasm: linkage to chromosome 9q13-q21 and evidence for genetic heterogeneity.

Authors:  P R Jarman; N W Wood; M T Davis; P V Davis; K P Bhatia; C D Marsden; M B Davis
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

10.  Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16.

Authors:  P Szepetowski; J Rochette; P Berquin; C Piussan; G M Lathrop; A P Monaco
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.